CAT-152

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2007
012320012007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To evaluate CAT-152 (lerdelimumab), a monoclonal antibody to transforming growth factor-beta2 (TGF-beta2), in… (More)
Is this relevant?
2007
2007
  • Ophthalmology
  • 2007
 
Is this relevant?
2006
2006
PURPOSE Inhibition of TGF-beta reduces myofibroblast differentiation and fibrosis in the cornea. Determining the actions of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
Transforming growth factor beta (TGFbeta), a potent inducer of cell transdifferentiation, is heavily implicated in fibrotic… (More)
Is this relevant?
Review
2005
Review
2005
It is generally accepted that transforming growth factor B (TGFB) is both a tumor suppressor and tumor promoter. Whereas loss or… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
There is increasing evidence implicating Transforming growth factor beta (TGF-beta) in pathological states of the lens. However… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE Postoperative subconjunctival wound healing remains the commonest cause of late bleb failure after glaucoma filtration… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE To study the role of TGF-beta2 in posterior capsule opacification (PCO) and to determine whether CAT-152 (lerdelimumab… (More)
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2002
2002
PURPOSE The human monoclonal antibody that neutralizes the growth factor TGFbeta(2) (CAT-152) safely and effectively inhibits in… (More)
Is this relevant?
2001
2001
Diabetic nephropathy is characterised by an increase in glomerular and tubular fibrosis that compromises kidney function. The… (More)
Is this relevant?